Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide in Pancreaticoduodenectomy
NCT02474914Completed
- Sponsor
- Mansoura University
- Start
- May 2014
- Primary completion
- Apr 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in pancreatic fistula (POPF) comparing Octreotide with Placebo (2 arms). Primary endpoint: Rate of development of postoperative pancreatic fistula at 30 days. Started May 2014; status: completed.
02
Drugs
octreotide
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT02474914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474914.